The management of patients with stroke is often multidisciplinary, involving various
specialties and healthcare professionals. Given the common shared risk factors for stroke …

These guidelines will be updated every four years. Vascular centres are encouraged to audit
implementations made as a result of the guidelines. Audit cycles should be repeated and …

Anticoagulation substantially reduces the risk of stroke in patients with atrial fibrillation (AF).
However, recent studies have shown that up to 22%–36% of patients on anticoagulation will …

Stroke care often involves a multidisciplinary effort, including the stroke physician, internist,
neurologist, interventionist, cardiologist, radiologist, vascular surgeon, neurosurgeon …

Antithrombotic therapy is a key element of secondary prevention in patients who have had
an ischaemic stroke or transient ischaemic attack. However, its use in clinical practice is not …

Carotid atherosclerotic disease continues to be an important cause of stroke, often disabling
or fatal. Such strokes could be largely prevented through optimal medical therapy and …

BACKGROUND AND PURPOSE: Antithrombotic therapy following carotid artery stent
placement with concomitant atrial fibrillation is not well-established. Our aim was to assess …

Background In post-stroke atrial fibrillation (AF) patients who have indications for both oral
anticoagulant (OAC) and antiplatelet agent (AP), eg, those with carotid artery stenosis, there …

Objectives To investigate whether the occurrence of ischemic stroke due to carotid stenosis
is a marker of the severity of atherosclerotic disease and of an excess risk of cardiovascular …

Objective This review aimed to summarize the evidence on the risk of thromboembolism
associated with carotid and aortic atherosclerosis in patients with AF, and the potential …